Editas Medicine, Inc. (EDIT)
3.00
-0.11
(-3.54%)
USD |
NASDAQ |
Aug 24, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Price to Book Value : 4.375 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.375 |
| August 21, 2026 | 4.535 |
| August 20, 2026 | 4.287 |
| August 19, 2026 | 4.740 |
| August 18, 2026 | 4.200 |
| August 17, 2026 | 4.142 |
| August 14, 2026 | 4.112 |
| August 13, 2026 | 4.098 |
| August 12, 2026 | 4.142 |
| August 11, 2026 | 4.302 |
| August 10, 2026 | 4.098 |
| August 07, 2026 | 4.200 |
| August 06, 2026 | 4.229 |
| August 05, 2026 | 4.010 |
| August 04, 2026 | 4.040 |
| August 03, 2026 | 3.864 |
| July 31, 2026 | 3.762 |
| July 30, 2026 | 3.923 |
| July 29, 2026 | 3.792 |
| July 28, 2026 | 3.821 |
| July 27, 2026 | 3.908 |
| July 24, 2026 | 3.792 |
| July 23, 2026 | 3.981 |
| July 22, 2026 | 4.054 |
| July 21, 2026 | 4.214 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.200 |
| July 17, 2026 | 4.346 |
| July 16, 2026 | 4.200 |
| July 15, 2026 | 4.433 |
| July 14, 2026 | 4.608 |
| July 13, 2026 | 4.608 |
| July 10, 2026 | 4.754 |
| July 09, 2026 | 4.812 |
| July 08, 2026 | 5.352 |
| July 07, 2026 | 5.469 |
| July 06, 2026 | 5.323 |
| July 02, 2026 | 5.323 |
| July 01, 2026 | 4.783 |
| June 30, 2026 | 4.725 |
| June 29, 2026 | 71.05 |
| June 26, 2026 | 63.28 |
| June 25, 2026 | 60.84 |
| June 24, 2026 | 62.17 |
| June 23, 2026 | 61.28 |
| June 22, 2026 | 62.17 |
| June 18, 2026 | 59.73 |
| June 17, 2026 | 56.62 |
| June 16, 2026 | 52.40 |
| June 15, 2026 | 54.62 |
| June 12, 2026 | 55.51 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Geron Corp. | 4.467 |
| Novavax, Inc. | -- |
| Recursion Pharmaceuticals, Inc. | 1.897 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.53 |
Price to Book Value Related Metrics
| PS Ratio | 6.454 |
| Price | 3.00 |
| Earnings Yield | -24.82% |
| Market Cap | 460.59M |